These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3124416

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vaccines against Pseudomonas aeruginosa infection: 1. Experimental studies.
    Stanislavsky ES, Joo I, Mashilova GM, Boolk VF, Boltutsy LG, Zakgeim DA, Severtśova MK, Yedvabnaya LS, Gladus MA, Fatkhinurova TI.
    Vaccine; 1985 Jun; 3(2):128-36. PubMed ID: 3929491
    [Abstract] [Full Text] [Related]

  • 5. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
    Stanislavskiĭ ES, Joó I, Bulk VF, Zhvanetskaia MI, Mashilova GM.
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
    [Abstract] [Full Text] [Related]

  • 6. A new polyvalent Pseudomonas vaccine.
    Miler JM, Spilsbury JF, Jones RJ, Roe EA, Lowbury EJ.
    J Med Microbiol; 1977 Feb; 10(1):19-27. PubMed ID: 402473
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I, Stanislavsky ES, Zhvanetskaya MI, Mashilova GM, Gladus MA.
    Acta Microbiol Acad Sci Hung; 1982 Feb; 29(4):267-75. PubMed ID: 6821018
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS, Priebe GP, Pier GB.
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes].
    Kholodkova EV, Fedotova IuM, Stanislavskiĭ ES.
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445
    [Abstract] [Full Text] [Related]

  • 15. [Problems of the immunoprophylaxis of experimental Pseudomonas pyocyanea wound sepsis].
    Kolker II, Stanislavskiĭ ES, Grishina IA.
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):67-72. PubMed ID: 110018
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
    Lieberman MM.
    Antibiot Chemother (1971); 1989 May; 42():193-202. PubMed ID: 2512837
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.